{"id":"W2803715345","doi":"10.1111/dom.13384","title":"Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Ezetimibe; PCSK9; Medicine; Internal medicine; Placebo; Diabetes mellitus; Statin; Endocrinology; Lipoprotein; Cholesterol; LDL receptor; Apolipoprotein A1; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007147484,0.0008807552,0.003046744,0.0003173729,0.0004778839,0.001190125,0.0004797728,0.0005390913,0.002783849],"category_scores_gemma":[0.005639362,0.0004217037,0.003916477,0.0004790784,0.0005648327,0.0008030552,0.0008125954,0.001405731,0.0001908543],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006202399,"about_ca_system_score_gemma":0.001503264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001505373,"about_ca_topic_score_gemma":0.005738125,"domain_scores_codex":[0.9969111,0.00213316,0.0002481914,0.0003485438,0.0002040891,0.0001550197],"domain_scores_gemma":[0.9972284,0.0009745032,0.0009507423,0.0002329459,0.0002647948,0.0003485837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9137935,0.0008970878,0.02254567,0.003919185,0.01775315,0.00007495363,0.000177684,0.0008107284,0.003903277,0.0001994816,0.002457651,0.03346764],"study_design_scores_gemma":[0.7372269,0.04679425,0.1610597,0.0008709013,0.04049237,0.0004923561,0.0001919289,0.00210602,0.002261284,0.001003563,0.00740091,0.00009980243],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.965932,0.02689527,0.0009032056,0.0006725908,0.0001310575,0.001044248,0.002385509,0.00006656261,0.001969552],"genre_scores_gemma":[0.9874177,0.006159562,0.001441202,0.0007422467,0.0001181989,0.001011309,0.002411619,0.00002343855,0.0006746954],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.007147484,"threshold_uncertainty_score":0.03780001,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03600435787991747,"score_gpt":0.2979348786396017,"score_spread":0.2619305207596842,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}